000 | 01593 a2200493 4500 | ||
---|---|---|---|
005 | 20250517214443.0 | ||
264 | 0 | _c20190807 | |
008 | 201908s 0 0 eng d | ||
022 | _a1107-0625 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Zhongyan | |
245 | 0 | 0 |
_aTherapeutic benefits of neoadjuvant and post-operative denosumab on sacral giant cell tumor: a retrospective cohort study of 30 cases. _h[electronic resource] |
260 |
_bJournal of B.U.ON. : official journal of the Balkan Union of Oncology _c |
||
300 |
_a453-459 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aDenosumab _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aGiant Cell Tumor of Bone _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 |
_aRANK Ligand _xgenetics |
650 | 0 | 4 |
_aSacrum _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aYang, Yi | |
700 | 1 | _aGuo, Wei | |
700 | 1 | _aYang, Rongli | |
700 | 1 | _aTang, Xiaodong | |
700 | 1 | _aYan, Taiqiang | |
700 | 1 | _aJi, Tao | |
700 | 1 | _aXie, Lu | |
700 | 1 | _aXu, Jie | |
700 | 1 | _aWang, Jun | |
773 | 0 |
_tJournal of B.U.ON. : official journal of the Balkan Union of Oncology _gvol. 23 _gno. 2 _gp. 453-459 |
|
999 |
_c28375462 _d28375462 |